Abstract:
A methodology to obtain in vitro large numbers of human induced regulatory T cells with specificity to the donor antigen, with a phenotype and stable suppressor function in the presence of pro-inflammatory cytokines, through of co-cultures of monocyte-derived dendritic cells and T cells “ naïve ”, both from genetically unrelated individuals (donor and recipient) is disclosed. The cells obtained with the present method are of CD4, CD25, CTLA-4 and FOXP3+ phenotype and show a specific suppressor function on donor antigen-specific T lymphocytes. These cells maintain their phenotype and stable suppressive function in presence of pro-inflammatory cytokines TNF-α and IL-6. The stability and the number obtained make them candidates as therapeutic tools for transplantation.
Abstract:
A process for manufacturing a nutraceutical tortilla prepared from wheat flour as an alternative for malnutrition and obesity, wherein two fermentations are carried out with probiotic microorganisms, lactic bacteria (Streptococcus thermophilus, Lactobacillus bulgaricus, Lactobacillus plantarum) and with Saccharomyces cerevisiae yeast and enriched with prebiotics (inulin), milk protein, calcium and folic acid, resulting in a high nutritional value product and with probiotic microorganisms, resulting in a tortilla that does not need preservative added during manufacturing thereof.
Abstract:
Three adhesives formulated with Trimethylolpropane Trimethacrylate (TMPTMA) that do not contain BisGMA were developed, whereby the mutagenic and teratogenic risk by the release of bisphenol A is eliminated, and presented a better performance compared to the three commercial adhesives prepared with BisGMA (Adhesive A, Adhesive C and Adhesive B). The invention provides an adhesive used in one-step and provides a system which is formed by a primer and a slurry. The adhesives of the invention were compared with two commercial controls. They were physically characterized by assessing: hardening time, adhesion stress, elastic modulus, sorption and solubility at different pHs (6.8 and 7.7); by the obtained values premature detachments, white lesions below the appliance and microfiltration are avoided; its fluidity, film thickness were evaluated and were compared with those obtained from the three commercial adhesives. Storage stability and thermogravimetric analysis were assessed. The prepared adhesives with TMPTMA are photopolymerizables, thereby providing enough time to the operator to place the appliance in proper position, it is easy to handle, capable of supporting orthodontic biomechanics, has low elastic modulus, enables transitions of heavy arches reducing the risk of involuntary detachment of the appliances, have low viscosity, penetrates on both the brace retentions as those made with acid etching on enamel surface. Presenting adhesion to both the base of the attachments as well as to the enamel, its film thickness is minimal and does not alter the prescription system. When the appliance is removed at the end of the treatment, it does not cause structural damage to the enamel because the adhesive remains on the enamel and can be removed easily with a rotary instrument.
Abstract:
An improvement of a worm gear reducer is provided where the output gear is substituted by a threaded chain, which is comprised of nut-like threaded bodies mounted on the extended rods of two endless parallel chains, thus the contact surfaces of the driving screw and the threaded chain is much greater than the contact surfaces of the worm gear reducer, and thus the load capacity and wear resistance are much higher. The screw applies the driving force at the centroid of the contact surface of the threaded chain. There are three embodiments depending of the type of the driving screw which may be either roller, ball or a plain translation screw. With the roller or the ball screws there is rolling contact and thus the efficiency of the present invention is higher than that of the worm gear reducer, which permits it to be used as an amplifier.
Abstract:
A method to obtain imidazoline mixtures capable of providing considerable energy savings during the manufacture process due to a notable reduction of process temperature and lower requirements of chemical raw materials, and it allows for the direct use of vegetable oils, instead of fatty acids or their esters, producing imidazolines containing a (2-hydroxyethyl) group on position one of the ring and on position 2, a hydrocarbonated chain, from the fatty acids present in coconut oil, palm oil, jathrofa or castor. Likewise, the application of these mixtures as corrosion inhibitors has been established, in addition to quaternized imidazolines, which have applications as cationic surfactants, fabric softeners, hair conditioners and antistatic agents. It is an optimized method that compared to other known methods, uses substoichiometric proportions of aminoethylethanolamine and lower reaction temperatures, without using dehydrating agents or catalysts, or azeotropic distillation, which involves the use of highly flammable solvents.
Abstract:
The present invention relates to a new composition of human recombinant antibody fragments in both single chain or Fab format, which is capable of completely neutralizing the venom of the scorpion Centruroides sculpturatus Ewing (C. sculpturatus. In particular the new composition comprises the scFv fragment 10FG2 (SEQ. ID. No: 1), which has broad cross-reactivity against various Mexican scorpion venom toxins, and the scFv fragment LR (SEQ. ID. No: 2), with more limited cross-reactivity. Alternatively, the new composition comprises the Fab 10FG2 fragment (SEQ. ID. No: 3 and SEQ.ID. No:4) and the Fab LR fragment (SEQ. ID. No: 5 and SEQ.ID. No 6). The two antibody fragments recognize independent epitopes, present in the two main toxins of the scorpion C. sculpturatus, so that they do not interfere with each other during their binding to the same, on the contrary the antibody fragments of the present invention complement the neutralizing activity.
Abstract:
The present invention provides a method to obtain DNA constructs that encode 3-domain Cry toxins (also called Cry toxins, Bt toxins, or β-endotoxins) lacking helix α-1. These DNA constructs have been modified to encode proteins that kill insects that are resistant to the corresponding unmodified Cry toxins. The DNA constructs encoding the Modified 3-Domain Cry Toxins and the encoded Modified 3-Domain Cry Toxins are provided together with the molecular vectors and the host cell comprising said constructs and the recombinant methods to produce the Modified 3-Domain Cry Toxins. Additionally, compositions comprising the Modified 3-Domain Cry Toxins are disclosed. The resistance of the insects to unmodified Cry toxins is due to reduced toxin binding to the insects' midgut receptors. The invention further provides methods to overcome resistance in crop pests.
Abstract:
The present invention relates to the preparation of catalysts used in the hydrodesulfurization of fossil fuels and proposes a method for preparing thermally stable, low-cost catalysts for the hydrodesulfurization of petrol and diesel, based on highly active CoMo and NiMo. The catalyst for the hydroprocessing of gasoil or petrol in the present invention comprises a precursor which consists of chemical compounds obtained from organic acids and metal salts, and a support containing an ultra-stable Y-type zeolite useful in the hydroprocessing of heavy gas oil and/or light cyclic gas oil with high conversion rates.
Abstract:
The present invention provides osteogenic peptides derived from the Cementum-derived attachment protein (HACD1/CAP) and another derived from the Cementum Protein 1 (CEMP1) and pharmaceutical compositions of these peptides for the prevention and treatment of osteopenia and osteoporosis. These peptides increase bone mineral density in an osteoporotic model and without in vivo side effects, demonstrating clinical effectiveness in the prevention and treatment of osteopenia and osteoporosis in vivo as well as bone repair and/or regeneration.
Abstract:
The biphasic extraction from coffee waste without a prior drying process, to obtain coffee oil, which is transesterified with KOH catalyzed methanol to produce mixtures of glycerol free methylic esters, also known as coffee oil biodiesel, which is subjected to an aminolysis reaction with aminoethylethanolamine (AEEA) by heating to 140-160° C. at atmospheric pressure with a subsequent dehydration reaction at the same temperature but at a reduced pressure of 200 to 300 mmHg, in order to achieve cyclization of the intermediary amides into the corresponding imidazolines. Alternatively process, coffee oil can be submitted to the same aminolysis procedure with aminoethylethanolamine (AEEA) at 140 to 160° C. and atmospheric pressure with a subsequent dehydration reaction at the same temperature but at a reduced pressure of 200 to 300 mmHg, to produce imidazolines that contain the residual glycerol of the original triglycerides.